JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB237712

Anti-CTLA4 antibody [CAL49]

Anti-CTLA4 항체 [CAL49]

4

(5 리뷰들)

|

(48 제품이 사용된 논문 )

Anti-CTLA4 antibody [CAL49] (ab237712) is a rabbit monoclonal antibody detecting CTLA4 in Western Blot, Flow Cytometry (Intra), IP, IHC-P. Suitable for Human, Mouse, Rhesus monkey.

- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications

대체 명칭 보기

CD152, CTLA4, Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, CTLA-4

11 이미지
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)

Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling CTLA4 with ab237712 at a concentration of 1µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins. ab237712 Anti-CTLA4 antibody [CAL49] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control. Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).

Flow Cytometry (Intracellular) - Anti-CTLA4 antibody [CAL49] (AB237712)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-CTLA4 antibody [CAL49] (AB237712)

Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed, 0.1% Tween 20 permeabilized human PBMC (peripheral blood mononuclear cell) (treated with 10μg/ml PHA for 2 days) cells labeling CTLA4 with ab237712 at 1/400 (Right) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (Left).

Cells were surface stained with anti-CD3 conjugated to Alexa Fluor® 647. Then fixed with 2% PFA for 10min followed by intracellular staining with rabbit IgG (Left) and ab237712 (Right).

Goat Anti-Rabbit IgG Fc (Alexa Fluor® 488) preadsorbed (ab150097), at 1/2000 dilution was used as the secondary antibody.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)

Formalin-fixed, paraffin-embedded human breast carcinoma tissue stained for CTLA4 using ab237712 at 0.25 μg/ml in immunohistochemical analysis.

Incubate with primary antibody for 75 minutes at room temperature.

Flow Cytometry (Intracellular) - Anti-CTLA4 antibody [CAL49] (AB237712)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-CTLA4 antibody [CAL49] (AB237712)

Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) (top) or PBMCs treated with 5µg/ml PHA for 48 Hours with ab237712 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left). PBMCs were incubated for 30 min on ice in 1x PBS containing 10 µg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interaction. Cells were then fixed and permeabilised with BD Cytofix/Cytoperm™ for 20 min followed by the antibody ab237712 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 106 in 100 µl at 0.2 μg/ml (1/10,300)) for 30 min at 22°C.

The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/2000 for 30min at 22°C.

Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on live cells.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)

Tissue Microarrays stained for "Anti-CTLA4 antibody [CAL49]" using "ab237712"in immunohistochemical analysis. This table provides a detailed overview of positive (tick mark) and negative (cross mark) staining per sample type tested. The sections were pre-treated using Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 30 minutes. The sections were incubated with ab237712 for 30 mins at room temperature followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling CTLA4 with ab237712 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) ready to use. Positive staining on human tonsil is observed. Counter stained with hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) ready to use.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 30 mins.

The section was incubated with ab237712 for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)

Formalin-fixed, paraffin-embedded human lymph node tissue stained for CTLA4 using ab237712 at 0.25 μg/ml in immunohistochemical analysis.

Incubate with primary antibody for 75 minutes at room temperature.

Immunoprecipitation - Anti-CTLA4 antibody [CAL49] (AB237712)
  • IP

Supplier Data

Immunoprecipitation - Anti-CTLA4 antibody [CAL49] (AB237712)

CTLA4 was immunoprecipitated from 0.35 mh human tonsil lysate with ab237712 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab237712 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used as secondary antibody at 1/1000 dilution.

Lane 1 : Human tonsil lysate 10 μg (Input).
Lane 2 : ab237712 IP in human tonsil lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab237712 in human tonsil lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.

All lanes:

Immunoprecipitation - Anti-CTLA4 antibody [CAL49] (ab237712)

Predicted band size: 24 kDa

Observed band size: 25 kDa

false

Flow Cytometry (Intracellular) - Anti-CTLA4 antibody [CAL49] (AB237712)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-CTLA4 antibody [CAL49] (AB237712)

Intracellular flow cytometric analysis of2% paraformaldehyde-fixed, 0.1% Tween 20 permeabilized mouse splenocytes (treated with 2.5μg/ml Concanavalin A (ConA) for 3 days) cells labeling CTLA4 with ab237712 at 1/400 (Right) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (Left).

Cells were surface stained with anti-CD3 conjugated to Alexa Fluor® 647. Then fixed with 2% PFA for 10min followed by intracellular staining with rabbit IgG (Left) and ab237712 (Right).

Goat Anti-Rabbit IgG Fc (Alexa Fluor® 488) preadsorbed (ab150097), at 1/2000 dilution was used as the secondary antibody.

Western blot - Anti-CTLA4 antibody [CAL49] (AB237712)
  • WB

Lab

Western blot - Anti-CTLA4 antibody [CAL49] (AB237712)

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-CTLA4 antibody [CAL49] (ab237712) at 1/1000 dilution

Lane 1:

Untreated human PBMC (human peripheral blood mononuclear cell) whole cell lysate at 20 µg

Lane 2:

Human PBMC (treated with 10μg/ml PHA for 2 days) whole cell lysate at 20 µg

Lane 3:

Untreated mouse splenocyte whole cell lysate at 20 µg

Lane 4:

Mouse splenocyte (treated with 2.5μg/ml Concanavalin A (ConA) for 3 days) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 24 kDa

Observed band size: 25 kDa

false

Exposure time: 3min

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)
  • IHC-P

Collaborator

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTLA4 antibody [CAL49] (AB237712)

Immunohistochemical analysis of paraffin-embeded Rhesus monkey tonsil tissue labeling CTLA4 with ab251599 followed by Polink 1 Polymer HRP anti-Rabbit IgG.

Heat mediated antigen retrieval-Buffer/Enzyme Used : Dako pH9.

This data was developed using the same antibody clone in a different buffer formulation (ab251599).

This image is courtesy of Dr. Chi Ngai Chan

관련 conjugated 항체와 다양한 조성의 항체 (4)

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

CAL49

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human, Rhesus monkey

Applications

Flow Cyt (Intra), IHC-P, WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/400", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/400", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rhesus monkey": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

제품 세부 정보

What is this antibody validated in?
Anti-CTLA4 antibody [CAL49] (ab237712) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human, Mouse, Rhesus monkey samples.

What is the molecular weight of CTLA4?
Anti-CTLA4 [CAL49] (ab237712) specifically detects a band for CTLA4 (UniProt: P16410) at a molecular weight of 25kDa.

Trusted by the scientific community
Anti-CTLA4 [CAL49] (ab237712) was first used in a scientific publication in 2018 and has been cited over 20 times in peer-reviewed journals.

Reviewed by scientists
Anti-CTLA4 [CAL49] (ab237712) has over 5 independent reviews from customers.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10μl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [CAL49] also available for your convenience: ab237712, Carrier free - ab251599, Alexa Fluor® 647 - ab270127, PE - ab270128, Alexa Fluor® 555 - ab283489

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein A
Purification 관련 사항
Purity >99%.
보관 버퍼
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: PBS
배송 시 보관 조건
Conditional Ambient
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

CTLA-4 also known as CD152 is an immune checkpoint receptor with a molecular weight of approximately 34 kDa. This protein is expressed on the surface of T-cells especially after activation and sometimes on regulatory T-cells (Tregs). CTLA-4 competes with CD28 for binding to the same ligands CD80 and CD86 on antigen-presenting cells. Unlike CD28 which stimulates T-cell activation CTLA-4 sends inhibitory signals to downregulate immune responses. By doing this CTLA-4 helps maintain immune system homeostasis and prevents autoimmune reactions.
Biological function summary

The CTLA-4 protein functions as a critical regulator of the immune system. It interacts with CD80/CD86 in a complex that effectively transmits inhibitory signals to T-cells. CTLA-4 controls the amplitude of the initial activation of T-cells ensuring that the body's immune responses are kept under control. In regulatory T-cells CTLA-4 engagement contributes to their immunosuppressive functions through which they maintain tolerance to self-antigens and prevent overactive immune reactions.

Pathways

CTLA-4 involves itself in the adaptive immune response pathways specifically the regulation of T-cell activity. CTLA-4's interaction with CD80/CD86 modulates pathways associated with TCR (T-cell receptor) signaling. When CTLA-4 binds its ligands it recruits phosphatases such as SHP-2 that dephosphorylate signaling proteins leading to the downregulation of T-cell interaction. This pathway interaction exemplifies how CTLA-4 acts in concert with proteins like CD28 to finely tune immune responses.

CTLA-4 plays a role in autoimmune diseases and cancer. The dysregulation of CTLA-4 function can lead to autoimmune disorders where the immune system attacks the body's own tissue. In cancer tumor cells may manipulate CTLA-4 pathways to evade immune surveillance. Targeted therapies like anti-CTLA-4 antibodies such as ipilimumab have been developed to block CTLA-4 aiming to enhance the immune system's ability to attack cancer cells. These treatments highlight the role of CTLA-4 in balancing immune activity and the potential to alter this balance for therapeutic benefit.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Inhibitory receptor acting as a major negative regulator of T-cell responses (PubMed : 11279501, PubMed : 11279502, PubMed : 16551244, PubMed : 1714933, PubMed : 18641304, PubMed : 28484017). Acts as a decoy receptor : the affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28 (PubMed : 11279501, PubMed : 11279502, PubMed : 16551244, PubMed : 1714933, PubMed : 28484017).
See full target information CTLA4

제품이 사용된 논문 (48)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Molecular medicine (Cambridge, Mass.) 31:278 PubMed40819077

2025

Targeting LINC02544/miR-497-5p/CAPRIN1 axis via exosome-based siRNA to overcome immunotherapy resistance in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Bin Lian,Jiayi Li,Shihui Tang,Ting Li,Jinping Li

Cellular & molecular biology letters 30:92 PubMed40713509

2025

FLNA, a disulfidptosis-related gene, modulates tumor immunity and progression in colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Qiong Li,Renhong Huang,Lingling Lv,Haifeng Ying,Yuan Wu,YuQing Huang,Yuxi Li,Wen Ma,Xiaoshuang Liu,Qinghui Meng,Fengying Xing,Yan Shen,Lan Zheng

Materials today. Bio 33:102045 PubMed40688666

2025

Dendritic cell membrane-based DCsLipo@MnO@siCTLA4@PD-1α nanomedicine for the treatment of Lynch syndrome-related colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjin Zhong,Pengcheng Wang,Jintian Wang,Yuejia Zhu,Liquan Chen,Yilong Qian,Xiang Huang,Kai Ye

International journal of molecular sciences 26: PubMed40565313

2025

Immune-Checkpoint Expression in Breast Cancer Patients: Clinicopathological Implications: A Retrospective Case Series Study.

Applications

Unspecified application

Species

Unspecified reactive species

Angel Quiroz-Bolaños,Antonio Quintero-Ramos,Juliana Marisol Godínez-Rubí,Ramon Franco-Topete,Porfirio Gutiérrez González,Bricia M Gutiérrez-Zepeda,Denisse S Becerra-Loaiza,Antonio Topete,Cesar de Loera-Rodriguez,Alicia Del Toro-Arreola,Adrián Daneri-Navarro

Journal of translational medicine 23:478 PubMed40281576

2025

scRNA-seq reveals that VEGF signaling mediates the response to neoadjuvant anlotinib combined with PD-1 blockade therapy in non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ziqi Huang,Li Li,Xiaohe Zhao,Haixia Jin,Meng Shen,Baihui Li,Yu Zeng,Qinfen Zhang,Qiyu Wang,Meng Wang,Lili Yang

Nature communications 16:3903 PubMed40281037

2025

Single-cell RNA sequencing dissects the immunosuppressive signatures in Helicobacter pylori-infected human gastric ecosystem.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Hu,Ze Min Chen,Ying Wang,Chao Yang,Zi Ying Wu,Li Juan You,Zhi Yong Zhai,Zhao Yu Huang,Ping Zhou,Si Lin Huang,Xia Xi Li,Gen Hua Yang,Chong Ju Bao,Xiao Bing Cui,Gui Li Xia,Mei Ping Ou Yang,Lin Zhang,William Ka Kei Wu,Long Fei Li,Li Kai Tan,Yu Xuan Zhang,Wei Gong

Clinical cancer research : an official journal of the American Association for Cancer Research 31:2495-2514 PubMed40192737

2025

Single-Cell Transcriptomic Landscape Deciphers Intratumoral Heterogeneity and Subtypes of Acral and Mucosal Melanomas.

Applications

Unspecified application

Species

Unspecified reactive species

Yunyan Li,Ziyang Cui,Xiaole Song,Yeqing Chen,Cang Li,Junfeng Shi,Wenkang Qian,Guoxin Ren,Jiang Zhou,Chunpu Li,Xiaoqing Ma,Yifan Chen,Dongdong Jia,Yongli Zhang,Zhilin Zhang,Ronghao Zhang,Zhaotian Zhang,Yong Chen,Zhixiang Xu,Wantao Chen,Xiao Miao,Hongmeng Yu,Jianxin Chen,Kai Wang,Colin R Goding,Zhi Wei,Tao Li,Rutao Cui

eLife 13: PubMed40067762

2025

Propionyl-CoA carboxylase subunit B regulates anti-tumor T cells in a pancreatic cancer mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Han V Han,Richard Efem,Barbara Rosati,Kevin Lu,Sara Maimouni,Ya-Ping Jiang,Valeria Montoya,Ando Van Der Velden,Wei-Xing Zong,Richard Z Lin

Medicina (Kaunas, Lithuania) 61: PubMed40005446

2025

Immunological Landscape of Non-Melanoma Skin Neoplasms: Role of CTLA4+IFN-γ+ Lymphocytes in Tumor Microenvironment Suppression.

Applications

Unspecified application

Species

Unspecified reactive species

Silvana Karabatić Knezović,Dora Knezović,Jelena Ban,Antonela Matana,Neira Puizina Ivić,Merica Glavina Durdov,Mladen Merćep,Irena Drmić Hofman

JID innovations : skin science from molecules to population health 5:100324 PubMed39803386

2025

Langerhans Cells Directly Interact with Resident T Cells in the Human Epidermis.

Applications

Unspecified application

Species

Unspecified reactive species

Tomonori Oka,Tatsuya Hasegawa,Truelian Lee,Valeria S Oliver-Garcia,Mahsa Mortaja,Marjan Azin,Satoshi Horiba,Sabrina S Smith,Sara Khattab,Kathryn E Trerice,Steven T Chen,Yevgeniy R Semenov,Shadmehr Demehri
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com